TheracosBio
John-Paul Lock is an experienced endocrinologist and diabetes specialist currently serving as the Diabetes Advisory Board Chairman and Core Faculty Member at MetroWest Medical Center since April 2015. With a robust background in clinical research, John-Paul oversees clinical trials and resident research as the Medical Director of Clinical Research. Additionally, John-Paul has held roles as Clinical Endocrinologist at HealthAlliance Hospital and has been involved with NEIRB as a Physician Member since June 2015. John-Paul's academic contributions include serving as an Assistant Professor of Medicine at the University of Massachusetts School of Medicine from 2009 to 2014. With a medical education that includes a Fellowship in Clinical Endocrinology from the University of Colorado Denver and a Doctor of Medicine from Saint Louis University, John-Paul is dedicated to advancing diabetes care through mentorship and research.
This person is not in any teams
TheracosBio
TheracosBio is a pharmaceutical company located in Marlborough, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health. TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin). Press release: https://bit.ly/3HtSZ6y